Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$70.37 USD

70.37
1,742,354

+0.14 (0.20%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $70.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Unlocking Q3 Potential of Henry Schein (HSIC): Exploring Wall Street Estimates for Key Metrics

by Zacks Equity Research

Get a deeper insight into the potential performance of Henry Schein (HSIC) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Staar Surgical (STAA) delivered earnings and revenue surprises of 115.79% and 1.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HSIC Gears Up for Q3 Earnings: Here's What You Need to Know

by Zacks Equity Research

Henry Schein is expected to report impressive sales in both its businesses in the third quarter of 2024, along with a low pace of recovery from the cyber incident.

Why Henry Schein (HSIC) Could Beat Earnings Estimates Again

by Zacks Equity Research

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Henry Schein Stock Gains From Dental Business Expansion Amid Macro Woe

by Zacks Equity Research

Henry Schein strategically sets up distribution centers worldwide to better serve customers and increase its operating efficiency.

HSIC Stock Likely to Get a Boost From New Henry Schein One Launches

by Zacks Equity Research

Henry Schein's dental software arm unveils Dentrix Eligibility offerings to elevate the insurance verification process.

Why Is Henry Schein (HSIC) Up 5.6% Since Last Earnings Report?

by Zacks Equity Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Henry Schein (HSIC) Hurt by Macroeconomic Woes, Cyber Attacks

by Zacks Equity Research

With sustained macroeconomic pressure, Henry Schein (HSIC) struggles to keep in check its cost of revenues and operating expenses.

Compared to Estimates, Henry Schein (HSIC) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Henry Schein (HSIC) Q2 Earnings Surpass, 2024 Guidance Slashed

by Zacks Equity Research

Henry Schein's (HSIC) second-quarter results reflect an improvement in sales trends in distribution businesses.

Henry Schein (HSIC) Q2 Earnings Beat Estimates

by Zacks Equity Research

Henry Schein (HSIC) delivered earnings and revenue surprises of 0.82% and 4.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Baxter International, Henry Schein and IDEXX Laboratories

by Zacks Equity Research

Baxter International, Henry Schein and IDEXX Laboratories are included in this Analyst Blog.

Urmimala Biswas headshot

What's in Store for These 3 MedTech Stocks in Q2 Earnings?

by Urmimala Biswas

MedTech companies' quarterly results are likely to be strong on a sequential basis. Let's see how BAX, HSIC and IDXX are placed ahead of their earnings releases.

Countdown to Henry Schein (HSIC) Q2 Earnings: Wall Street Forecasts for Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Henry Schein (HSIC) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

McKesson (MCK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dentsply International (XRAY) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Dentsply (XRAY) delivered earnings and revenue surprises of -2% and 1.16%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Henry Schein (HSIC) Q2 Earnings Expected to Decline

by Zacks Equity Research

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Henry Schein (HSIC) is a Strong Momentum Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

How to Play Henry Schein (HSIC) Ahead of Q2 Earnings?

by Zacks Equity Research

Henry Schein (HSIC) is expected to deliver impressive sales in both its businesses in the second quarter of 2024, along with a steady pace of recovery from the cyber incident.

Here's Why Henry Schein (HSIC) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Strength Seen in Henry Schein (HSIC): Can Its 5.4% Jump Turn into More Strength?

by Zacks Equity Research

Henry Schein (HSIC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Is It Wise to Retain Henry Schein (HSIC) in Your Portfolio Now?

by Zacks Equity Research

Robust acquisitions and a widespread distribution network bode well for Henry Schein's (HSIC) operations.

Henry Schein (HSIC) Banks on Strategic Buyouts Amid Macro Issues

by Zacks Equity Research

Henry Schein's (HSIC) revenue growth is supported by niche acquisitions and partnerships.